Intellia Therapeutics Inc sell StockNews.com
Start price
11.05.24
/
50%
€22.51
Target price
11.05.25
-
Performance (%)
-67.08%
End price
12.05.25
€7.41
Summary
This prediction ended on 12.05.25 with a price of €7.41. StockNews_com correctly predicted massive losses of -67.08% for Intellia Therapeutics Inc. StockNews_com has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -1.907% | -1.907% | -9.171% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.06
08.11.25
08.11.25
-
08.11.26
08.11.26
2.25%
31.07.26
31.07.26
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
18.01.26
18.01.26
-
18.01.27
18.01.27
-12.64%
31.07.26
31.07.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.90
27.12.25
27.12.25
-
27.12.26
27.12.26
17.19%
31.07.26
31.07.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.77
30.11.25
30.11.25
-
30.11.26
30.11.26
19.21%
31.07.26
31.07.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25